Persistent URL of this record https://hdl.handle.net/1887/122105
In Collections
This item can be found in the following collections:
Effect of the PCSK9 Inhibitor Evolocumab on Total Cardiovascular Events in Patients With Cardiovascular Disease: A Prespecified Analysis From the FOURIER Trial
- All authors
- Murphy, S.A.; Pedersen, T.R.; Gaciong, Z.A.; Ceska, R.; Ezhov, M.V.; Connolly, D.L.; Jukema, J.W.; Toth, K.; Tikkanen, M.J.; K. im; Wiviott, S.D.; Kurtz, C.E.; Honarpour, N.; Giugliano, R.R.; Keech, A.C.; Sever, P.S.; Sabatine, M.S.
- Date
- 2019-07-01
- Journal
- JAMA Cardiology
- Volume
- 4
- Issue
- 7
- Pages
- 613 - 619